Alphavirus infection
Asymmetric periflexural exanthem of childhood (unilateral laterothoracic exanthem)
B virus infection
Boston exanthem disease
Bovine papular stomatitis
Bowenoid papulosis
Buffalopox
Butchers wart
Chikungunya fever
Condylomata acuminata
Congenital rubella syndrome
Cowpox
Cytomegalic inclusion disease
Dengue (Break-bone fever)
Disseminated herpes zoster
Eczema herpeticum (Kaposis varicelliform eruption) 
Eczema vaccinatum
Epidermodysplasia verruciformis
Eruptive pseudoangiomatosis
Erythema infectiosum (fifth disease, slapped cheek disease)
Exanthem of primary HIV infection (acute retroviral syndrome)
Farmyard pox
Generalized vaccinia
Genital herpes (herpes genitalis, herpes progenitalis)
Gianotti–Crosti syndrome (infantile papular acrodermatitis, papular acrodermatitis of childhood, papulovesicular acrolocated syndrome)
Giant condyloma acuminatum (Buschke–Löwenstein tumor, giant condyloma of Buschke–Löwenstein tumor)
Hand-foot-and-mouth disease
Hecks disease (focal epithelial hyperplasia)
Hemorrhagic fever with renal syndrome
Hepatitis B
Hepatitis C
Herpangina
Herpes gladiatorum (scrum pox)
Herpes simplex
Herpes zoster oticus (Ramsay–Hunt syndrome)
Herpetic keratoconjunctivitis
Herpetic sycosis
Herpetic whitlow
HIV-associated pruritus
Human monkeypox
Human T-lymphotropic virus 1 infection
Human tanapox
Immune reconstitution inflammatory syndrome (immune recovery syndrome)
Infectious mononucleosis (glandular fever)
Inflammatory skin lesions following zoster infection (isotopic response)
Intrauterine herpes simplex 
Kaposi sarcoma
Lassa fever
Lipschütz ulcer (ulcus vulvae acutum)
Measles (rubeola, morbilli)
Milkers nodule
Modified varicella-like syndrome
Molluscum contagiosum
Myrmecia
Neonatal herpes simplex
Ophthalmic zoster
Orf (contagious pustular dermatosis, ecthyma contagiosum, infectious labial dermatitis, sheep pox)
Orf-induced immunobullous disease
Orolabial herpes (herpes labialis)
Papular purpuric gloves and socks syndrome
Pigmented wart
Postherpetic neuralgia (zoster-associated pain)
Post-vaccination follicular eruption
Progressive vaccinia (vaccinia gangrenosum, vaccinia necrosum)
Pseudocowpox
Recurrent respiratory papillomatosis (laryngeal papillomatosis) 
Rift Valley fever
Roseola infantum (exanthem subitum, exanthema subitum, sixth disease)
Roseola vaccinia
Rubella (German measles)
Sandfly fever (Pappataci fever, phlebotomus fever)
Sealpox
Varicella (chickenpox)
Variola major (smallpox)
Verruca plana (flat wart)
Verruca plantaris (plantar wart)
Verruca vulgaris (wart)
Verrucae palmares et plantares
Viral-associated trichodysplasia (ciclosporin-induced folliculodystrophy)
Wasting syndrome
West Nile virus infection
Zoster (herpes zoster, shingles)
Zoster sine herpete

Lichenoid eruptions
Lichenoid eruptions are dermatoses related to the unique, common inflammatory disorder lichen planus, which affects the skin, mucous membranes, nails, and hair.
With an overall risk of death of the fetus due to the repeated procedures of about 3% (17 deaths out of 485 pregnancies).In addition, given the short life span of transfused platelets, transfusions are needed regularly, increasing the overall risk of death of the baby. If intrauterine platelet transfusions are performed, they are generally repeated weekly (platelet lifespan after transfusion is approximately 8 to 10 days). Platelets administered to the fetus must be negative for the culprit antigen (often HPA-1a, as stated above). Many blood suppliers (such as American Red Cross; NHS Blood and Transplant; United Blood Services) have identified HPA-1a and 5b negative donors. An alternative donor is a mother who is, of course, negative for the culprit antigen. However, she must meet general criteria for donation and platelets received from the mother must be washed to remove the offending alloantibody and irradiated to reduce the risk of graft-versus-host disease. If platelet transfusions are needed urgently, incompatible platelets may be used, with the understanding that they may be less effective and that the administration of any blood product carries risk.Any administered cellular blood products must be irradiated to reduce the risk of graft-versus-host disease in the fetus. Additionally, all administered blood products should be CMV reduced-risk (CMV seronegative and leukoreduced are considered essentially equivalent for the purposes of CMV risk reduction). Non-invasive management
The use of Intravenous immunoglobulin (IVIG) during pregnancy and immediately after birth has been shown to help reduce or alleviate the effects of NAIT in infants and reduce the severity of thrombocytopenia.